Atlas FDA

WiSE (Wireless Stimulation of the Endocardium Technology) CRT System

FDA premarket approval P240028/S003 · decided 2025-10-03

Approval details

PMA number
P240028
Supplement
S003
Supplement type
Special (Immediate Track)
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
WiSE (Wireless Stimulation of the Endocardium Technology) CRT System
Generic name
Leadless Cardiac Resynchronization Therapy (CRT)
Applicant
EBR Systems, Inc.
Date received
2025-09-10
Decision date
2025-10-03
Days to decision
23 days
Decision code
APPR
Product code
SEG
Advisory committee
Cardiovascular
Expedited review
No
Location
Sunnyvale, CA
Statement
approval for an additional energy calibration inspection for the Transmitter subassembly

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.